- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in Telithromycin transport
Bibliographic Information
- Title
- Involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in Telithromycin transport
- Other Title
-
- テリスロマイシンの生体膜輸送機構における薬物トランスポーター糖蛋白質および多剤耐性関連蛋白(Mrp2)への関与
- Author
- 山口, 昌之
- Author
- Yamaguchi, Shoji
- University
- NAGOYA University
- Types of degree
- 博士(医療技術学)
- Grant ID
- 甲第7282号
- Degree year
- 2007-03-23
Search this Article
Description
The preset study aims to investigate the role of P glycoprotein and multidrug resistance-associated protein (Mrp2) in the transport of telithromycin, a newly developed ketolide antibiotic, in vitro and in vivo. The in vitro experiments revealed that the intracellular accumulation of telithromycin in adriamycin-resistant human chronic myelogenous leukemia cells (K562/ADR) overexpressing P glycoprotein was significantly lower than that in human chronic myelogenous leukemia cells (K562/S) not expressing P glycoprotein. Cyclosporine significantly increased the intracellular accumulation of telithromycin in K562/ADR cells. When telithromycin was coadministered intravenously with cyclosporine in Sprague-Dawley (SD) rats, cyclosporine significantly delayed the disappearance of telithromycin from plasma and decreased its systemic clearance to 60% of the corresponding control values. Hepatobiliary excretion experiments revealed that cyclosporine almost completely inhibited the biliary clearance of telithromycin, suggesting that telithromycin is a substrate of P glycoprotein and a potential substrate of Mrp2. Moreover, the biliary clearance of telithromycin was significantly decreased by 80% in Eisai hyperbilirubinemic mutant rats with a hereditary deficiency in Mrp2, indicating that Mrp2, as well as P glycoprotein, plays an important role in the biliary excretion of telithromycin. When the effect of telithromycin on the biliary excretion of doxorubicin, a substrate of P glycoprotein and Mrp2, was examined in SD rats, telithromycin significantly decreased the biliary clearance of doxorubicin by 80%. Results obtained from this study indicate that telithromycin is a substrate of both P glycoprotein and Mrp2, and these transporters are involved in the hepatobiliary transport of telithromycin.
- Tweet
Details 詳細情報について
-
- CRID
- 1910020910737889664
-
- NII Article ID
- 500001221475
- 500001604245
- 500000376259
-
- HANDLE
- 2237/10683
-
- NDL BIB ID
- 000008552387
-
- Text Lang
- en
-
- Data Source
-
- IRDB
- NDL Search